A Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia

Background: The present study investigated the patients with Chronic Myeloid Leukemia in chronic phase (CP-CML) who had been on the first- line Imatinib Mesylate (IM) therapy for a period of 84 months. Materials and Methods: This retrospective study was conducted in 295 newly-diagnosed CP-CML patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Nekoohesh, Ladan, Ghahremani, Mohammad H., Rostami, Shahrbano, Nikbakht, Mohsen, Nekoohesh, Leila, Naemi, Roozbeh, Mohammadi, Saeed, Ghadyani Nejad, Laya, Mousavi, Seyed Asadollah, Vaezi, Mohammad, Alimoghaddam, Kamran, Chahardouli, Bahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167602/
https://www.ncbi.nlm.nih.gov/pubmed/32337010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167602/
https://www.ncbi.nlm.nih.gov/pubmed/32337010

Ejemplares similares